TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
IFRX

InflaRx N.V.

Healthcare · Biotechnology

1.90$ +2.2% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow IFRX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – -5,260.6% – – – – – -59,935.9% -29,288.2% -115,647.5%
– – 30.7% – – – – – 900.0% 292.6% 1,373.7%
– – 1,969.7% – – – – – 5,412.2% 2,452.4% 15,153.4%
– – 4,083.6% – – – – – – – –
– – 1,117.7% – – – – – 1,590.7% -1,374.4% 15,902.8%
– – 64.5% – – – – – 128.5% 28.3% 378.9%
– – -72.3% – – – – – -28,050.2% 31,584.9% 10,587.6%
– – 0.0% – – – – – – – –
– – 51,070.6% – – – – – – – –
– – -128.1% – – – – – -592.8% -234.1% -1,219.1%
– – 47,100.0% – – – – – 83,986.5% 233.1% 109,105.5%
– – 40,764.1% – – – – – -5,543.6% 3,382.6% -612.5%
– – -5,325.1% – – – – – -60,064.5% -29,316.5% -116,026.4%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?